Please login to the form below

Not currently logged in
Email:
Password:

Ono Pharmaceutical

This page shows the latest Ono Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.

Merck settles PD-1 patent lawsuit with BMS and Ono

Merck settles PD-1 patent lawsuit with BMS and Ono

Merck settles PD-1 patent lawsuit with BMS and Ono. Agrees to pay $625m settlement plus royalties on sales of Keytruda until 2026. ... The US drugmaker has agreed to pay Bristol-Myers Squibb and Ono Pharmaceutical $625m to settle the patent infringement

Latest news

More from news
Approximately 4 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    Clearly on a roll with Japan, X-Chem has also signed a deal with Ono Pharmaceutical covering oncology targets. ... 190. Ambest Pharmaceutical. Sihuan Pharmaceutical. Acquisition. Manufacturing of injectables. 160. X-Chem.

  • Deal Watch July 2016 Deal Watch July 2016

    In the second immuno-therapy deal to make the top 20 this month ONO Pharmaceuticals paid $12.5m upfront for the rights to develop Celyad's phase I product, allogeneic ... Acquisition. 325. Celyad/ ONO Pharmaceutical. Allogeneic NKR-2 T-cell immunotherapy.

  • Pharma deals during July 2014 Pharma deals during July 2014

    tremelimumab. Existing partners Bristol-Myers Squibb (BMS) and Ono Pharmaceutical also announced that they will jointly develop and commercialise multiple immunotherapies as single and combination treatments.

  • Pharma deals during August 2013 Pharma deals during August 2013

    Onyx has sole marketing rights with the exception of Japan where it is licensed to Ono Pharmaceutical. ... the UK pharmaceutical market (11 per cent sales growth over the previous year) and will clearly strengthen Stada Arzneimittel's UK footprint.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics